TGRN.F Stock Overview
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Tong Ren Tang Technologies Co. Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.86 |
52 Week High | HK$0.86 |
52 Week Low | HK$0.85 |
Beta | 1.05 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | 38.97% |
5 Year Change | n/a |
Change since IPO | -46.15% |
Recent News & Updates
Recent updates
Shareholder Returns
TGRN.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | 0.3% | 1.9% |
1Y | n/a | 25.0% | 31.1% |
Return vs Industry: Insufficient data to determine how TGRN.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how TGRN.F performed against the US Market.
Price Volatility
TGRN.F volatility | |
---|---|
TGRN.F Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 9.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TGRN.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine TGRN.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1669 | 4,030 | Jia Fu Chen | https://www.tongrentangkj.com |
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services.
Tong Ren Tang Technologies Co. Ltd. Fundamentals Summary
TGRN.F fundamental statistics | |
---|---|
Market cap | US$856.38m |
Earnings (TTM) | US$87.88m |
Revenue (TTM) | US$961.69m |
9.7x
P/E Ratio0.9x
P/S RatioIs TGRN.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
TGRN.F income statement (TTM) | |
---|---|
Revenue | CN¥6.92b |
Cost of Revenue | CN¥4.06b |
Gross Profit | CN¥2.87b |
Other Expenses | CN¥2.23b |
Earnings | CN¥632.72m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Mar 22, 2024
Earnings per share (EPS) | 0.49 |
Gross Margin | 41.39% |
Net Profit Margin | 9.14% |
Debt/Equity Ratio | 15.7% |
How did TGRN.F perform over the long term?
See historical performance and comparison